Literature DB >> 6219601

T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia.

J C Goldsmith, P L Moseley, M Monick, M Brady, G W Hunninghake.   

Abstract

T-lymphocyte populations in 12 apparently healthy heterosexual adult patients with hemophilia have been examined to ascertain if these patients have abnormalities in their lymphocyte subpopulations similar to those in homosexual men, Haitian refugees, and narcotic addicts. A striking reduction in the helper to suppressor cell ratio ([0.86 +/- 0.14]:1) was found in 9 of the 12 patients. These abnormalities were similar to those previously described in two patients with hemophilia critically ill with Pneumocystis carinii pneumonia, and in homosexual men. The abnormality in the ratio of helper to suppressor T cells may be related to the continual exposure of patients with hemophilia to commercial clotting factor concentrates. However, these patients with abnormal T-lymphocyte subpopulations remain healthy. At present there is insufficient evidence to advocate a change in therapeutic practices in patients with hemophilia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219601     DOI: 10.7326/0003-4819-98-3-294

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

Review 1.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

2.  AIDS and the use of blood components and derivatives: the Canadian perspective.

Authors:  J B Derrick
Journal:  Can Med Assoc J       Date:  1984-07-01       Impact factor: 8.262

3.  Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.

Authors:  J A Brieva; J Sequi; J M Zabay; A Pardo; A Campos; M Luz de la Sen; A Bootello
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

4.  Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.

Authors:  J S Smolen; P Bettelheim; U Köller; S McDougal; W Graninger; T A Luger; W Knapp; K Lechner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

5.  Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).

Authors:  C R Horsburgh; K C Davis; U Hasiba; S H Weiss; J J Goedert; P Sarin; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

6.  Immunologic findings in healthy Haitians in Montreal.

Authors:  A Adrien; M Desrosiers; L Frappier-Davignon; W O Spitzer; J M Dupuy
Journal:  CMAJ       Date:  1985-09-01       Impact factor: 8.262

7.  Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?

Authors:  K S Froebel; R Madhok; C D Forbes; S E Lennie; G D Lowe; R D Sturrock
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

8.  Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

Authors:  U Köller; O Majdic; K Liszka; H Stockinger; I Pabinger-Fasching; K Lechner; W Knapp
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  Changing biclonal gammopathy due to different lymphocyte clones in acquired immunodeficiency syndrome with Kaposi's sarcoma.

Authors:  H Piechowiak; R Hehlmann; J Abb; V Erfle; F D Goebel; M M Kochen; G Kreeb
Journal:  Klin Wochenschr       Date:  1985-10-15

Review 10.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.